NCT03420248

Brief Summary

The primary purpose of this study is to compare pain after uterine artery embolization using non-spherical polyvinyl alcohol particles or tris-acryl gelatin microsphere in patients with symptomatic fibroids

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 5, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

April 19, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2019

Completed
Last Updated

September 19, 2019

Status Verified

September 1, 2019

Enrollment Period

10 months

First QC Date

January 16, 2018

Last Update Submit

September 17, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity by numerical rating scale

    0-10 numerical rating scale (0, no pain at all; 10, worst pain imaginable

    0-24 h after UAE

Secondary Outcomes (7)

  • C-reactive protein

    24 h after UAE

  • White blood cell count

    24 h after UAE

  • Neutrophil percentage

    24 h after UAE

  • Neutrophil-to-lymphocyte ratio

    24 h after UAE

  • Platelet-to-lymphocyte ratio

    24 h after UAE

  • +2 more secondary outcomes

Study Arms (2)

Non-spherical polyvinyl alcohol particle

EXPERIMENTAL

For embolic material, non-spherical polyvinyl alcohol particle is used.

Device: Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere

Tris-acryl gelatin microsphere

EXPERIMENTAL

For embolic material, Tris-acryl gelatin microsphere is used.

Device: Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere

Interventions

One of non-spherical polyvinyl alcohol particle or tris-acryl gelatin microsphere is used for embolic materials. All other processes are same.

Non-spherical polyvinyl alcohol particleTris-acryl gelatin microsphere

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Uterine artery embolization due to multiple fibroids

You may not qualify if:

  • Severe liver or kidney dysfunction
  • Drug allergy
  • Bradycardia (\<45 bpm) or heart block
  • Uncontrolled hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sesverance Hospital, Yonsei University College of Medicine

Seoul, 03722, South Korea

Location

MeSH Terms

Conditions

Leiomyoma

Condition Hierarchy (Ancestors)

Neoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Study Officials

  • So Yeon Kim, MD, PhD

    Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine

    PRINCIPAL INVESTIGATOR
  • Man Deuk Kim, MD, PhD

    Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

January 16, 2018

First Posted

February 5, 2018

Study Start

April 19, 2018

Primary Completion

February 8, 2019

Study Completion

May 8, 2019

Last Updated

September 19, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations